Data from the National Down Syndrome Cytogenetic Register is used to describe the cytogenetics and epidemiology of registered cases. The register comprises notifications from cytogenetics laboratories in England and Wales. This report is of 5737 cases registered between 1989 and 1993: 2169 prenatal and 3436 postnatal diagnoses, and 132 spontaneous abortions. Eighty eight registrations were from multiple pregnancies.
The National Down Syndrome Cytogenetic Register' receives reports of cases found to have a karyotype characteristic of phenotypic Down syndrome from all clinical cytogenetic laboratories in England and Wales. It is estimated that it comprises reports relating to about 94% of Down syndrome (DS) births in England and Wales, and data on nearly all DS terminations.2
This report relates to 5737 cases registered in the calendar years 1989 to 1993, including 3516 livebirths, which are derived from a cohort of about 3-5 million live births.
The size and representative nature of this data set make it possible to present extensive descriptive data on the different karyotypic subgroups which contribute to the Down syndrome phenotype, including parental age, sex ratio, and pregnancy outcome.
Methods

DATA COLLECTION
The methods of data collection and processing have been described previously. 1 No details are available of the cytogenetic techniques used but it is assumed that standard current practices apply, including the identification of chromosomes at moderate banding levels. In only two cases reported was banding unsuccessful, diagnosis resting on the presence ofan additional small acrocentric chromosome.
Both amniotic fluid and chorionic villus samples are susceptible to pseudomosaicism from maternal contamination or confined placental mosaicism. To our knowledge the techniques used usually involve multiple analyses with results derived from two or more cultures and, if mosaic, a repeat sample if time permits. Laboratory standards are monitored through the United Kingdom National External Quality Assessment Scheme in Clinical Cytogenetics (NEQAS).
PREGNANCY OUTCOME
The laboratories report any information they have on pregnancy outcome but for prenatally diagnosed cases the notification of the karyotype is often received before the outcome of pregnancy is known. In about half of the cases, information about outcome is sent to the register by the referring clinician, and in the remainder, the data managers of the register follow up prenatal diagnoses to determine the outcome. At the time of the preparation of the present report this was missing for nearly 8% of prenatal diagnoses reported (168/2169).
INCLUSIONS AND EXCLUSIONS
The present account includes information on all eligible cases pre-and postnatally diagnosed 21. In these there was a raised mean maternal age regardless of whether or not the structural anomaly had been inherited (table 5) .
SEX RATIO BY KARYOTYPE Table 6 gives the sex ratio by karyotype. In all karyotype groups other than the mosaics there was a marked excess of males. The overall sex ratio was 1 -23, but that of the reported mosaics was 0-53. This female excess in mosaics was most marked in those diagnosed prenatally with a ratio of 0-29. The female bias was seen also in liveborn mosaics with a ratio of 0-80. In affected twins discordant for Down syndrome the sex ratio was 0A47 (see below).
In the 12 cases of double aneuploidy which involved sex chromosomes, there were nine cases of 48,XXY, + 21, one 48,XYY, + 21, one 48,XXX, +21, and one mosaic with one cell line of 45,X. Among the nine translocations inherited from the father there were eight males and one female Down syndrome, while among the 42 of maternal origin there were equal numbers of males and females (table 5) .
Two births on the register were reported with anomalous sex, one 47,XX, +21 with a male phenotype, the other a "female" with karyotype 46,XY,t(21;21). Further details on these are awaited.
MULTIPLE BIRTHS
Included in the 5737 cases described in this account were 66 twins with a normal co-twin, 45 females, 21 males (sex ratio 0A47), and nine twin pairs who were concordant for sex and trisomy 21, six male-male and three femalefemale pairs (sex ratio 2 0). In four cases the birth notified to the register was one of a set of triplets. The sex of the co-twin of those not concordant for DS was often not given, but of the discordant co-twins for whom sex was known, 13 were female and 18 male (sex ratio 1 38). The four affected triplets were all female.
The laboratories are not always informed if a referred case was one of a multiple birth, and the clinicians were not asked this question in the early years of the register. Multiple births may therefore be underascertained.
The crude rate per thousand of the twin maternities which included one or more registered cases is 1-5%, slightly raised compared with that of 1 2% in the newborn population.8 However, this comparison makes no allowance for the terminations carried out of affected twins, nor for the raised risk of both twinning and DS associated with increasing maternal age. Further studies into the multiple births are in progress.
Discussion
The data reported here represent the largest national consecutive series of trisomy 21 diagnoses known to us, and we comment below on features of particular interest.
KARYOTYPIC SUBGROUPS
The distribution of different anomalies associated with DS is very similar to that in earlier reports.'0 Regular trisomy 21, without any associated chromosomal anomaly, is reported in 94% of all cases, and an unbalanced Robertsonian translocation involving chromosome 21 in 3-7%. The overall rate of translocation of 5% in the births (table 2) is a little lower than in previous reports (5 6%,"1 5 2% in liveborn," 6-8% in newborn'3), but the actual level will depend on the maternal age distribution and the rate of, and indications for, prenatal diagnosis.
The present data gave an opportunity to ascertain whether the frequency of non-contributory translocations associated with free trisomy differs from that found in newborn series. Hook et al'4 and Jacobs et al'5 have revised published estimates for such series allowing for the effect of the introduction of banding techniques. Many of the data on the frequency of chromosome anomalies are derived from population studies on newborn infants.'6 Considering only livebirths with free trisomy, the frequency ofassociated balanced reciprocal and Robertsonian translocations in the register data was 0 121 % (four in 3306) (excluding 11 with double aneuploidy). This is lower than the rate in newborn infants of reciprocal and Robertsonian translocations estimated by Jacobs et al'5 (0-264%:0 242%) or that estimated by Hook et all4 (0 275%). The 2143 pregnancy outcomes with free trisomy, other than livebirths, included 11 with associated non-contributory translocations (0-513%), compared with the 0-367% described by Jacobs et all5 in cases referred for prenatal diagnosis.
MATERNAL AGE
As expected, the register data show marked differences between maternal ages in the different karyotype groups ranging from a mean of 27-2 years in 213 cases with translocations involving chromosome 21, to 32-2 years in the group with mosaicism, 32-9 years in regular trisomy 21, 36-6 in those with free trisomy 21 and a non-contributory translocation, and 37-5 years in the 23 cases of double aneuploidy of known maternal age (table 3) .
Mean maternal age was low in all the contributory translocation groups, 27 
